Genmab A/S
NASDAQ:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
NASDAQ:GMAB
Watchlist
Price: 20.59 USD 0.24% Market Closed
Market Cap: 13.1B USD

Wall Street
Price Targets

GMAB Price Targets Summary
Genmab A/S

Wall Street analysts forecast GMAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GMAB is 32.97 USD with a low forecast of 15.44 USD and a high forecast of 47.67 USD.

Lowest
Price Target
15.44 USD
25% Downside
Average
Price Target
32.97 USD
60% Upside
Highest
Price Target
47.67 USD
132% Upside
Genmab A/S Competitors:
Price Targets
ITOS
Iteos Therapeutics Inc
250% Upside
145020
Hugel Inc
17% Upside
086890
Isu Abxis Co Ltd
85% Upside
COYA
Coya Therapeutics Inc
166% Upside
6955
Shandong Boan Biotechnology Co Ltd
2% Downside
CDNA
CareDx Inc
71% Upside
NIOX
Niox Group PLC
32% Upside
SANN
Santhera Pharmaceuticals Holding AG
72% Upside

Revenue
Forecast

Revenue Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's revenue is 36%. The projected CAGR for the next 3 years is 16%.

36%
Past Growth
16%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's operating income is 27%. The projected CAGR for the next 3 years is 19%.

27%
Past Growth
19%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Genmab A/S

For the last 8 years the compound annual growth rate for Genmab A/S's net income is 27%. The projected CAGR for the next 3 years is 10%.

27%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GMAB's stock price target?
Price Target
32.97 USD

According to Wall Street analysts, the average 1-year price target for GMAB is 32.97 USD with a low forecast of 15.44 USD and a high forecast of 47.67 USD.

What is Genmab A/S's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Genmab A/S's revenue is 36%. The projected CAGR for the next 3 years is 16%.

What is Genmab A/S's Operating Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Genmab A/S's operating income is 27%. The projected CAGR for the next 3 years is 19%.

What is Genmab A/S's Net Income forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Genmab A/S's net income is 27%. The projected CAGR for the next 3 years is 10%.

Back to Top